Overall, these results suggest that the SMAD3-dependent gene signature is present in hypoxic tumors and that VIM and ITGB2 are better predictors of metastasis or cancer recurrence in lung carcinoma and breast cancer than RHOB. This evidence concerns the gene SMAD3 and breast carcinoma.